Literature DB >> 11171838

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

H Jayaram1, J Satsangi, R W Chapman.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11171838      PMCID： PMC1760140          DOI： 10.1136/gut.48.3.430

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  17 in total

Review 1.  Inflammatory bowel disease: the problems of dysplasia and surveillance.

Authors:  P J Mitchell; E Salmo; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

2.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 3.  Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines.

Authors:  Wen-Chi L Chang; Terry V Zenser; Harry S Cooper; Margie L Clapper
Journal:  Cancer Lett       Date:  2013-02-13       Impact factor: 8.679

Review 4.  Medical and Surgical Management of Pediatric Ulcerative Colitis.

Authors:  José M Cabrera; Thomas T Sato
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

5.  Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Masaaki Okubo; Hiromi Yamashita; Daisuke Yoshioka; Joh Yonemura; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Virchows Arch       Date:  2011-01-14       Impact factor: 4.064

Review 6.  Surgical management of ulcerative colitis.

Authors:  Malika Bennis; Emmanuel Tiret
Journal:  Langenbecks Arch Surg       Date:  2011-09-16       Impact factor: 3.445

7.  Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Authors:  Johan Fevery; Chris Verslype; Gillian Lai; Raymond Aerts; Werner Van Steenbergen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 8.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 9.  Clinical features and management of primary sclerosing cholangitis.

Authors:  Marina-G Silveira; Keith-D Lindor
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

10.  Management of colorectal cancer in patients with inflammatory bowel disease.

Authors:  D O Kavanagh; M C Carter; D Keegan; G Doherty; M J Smith; J M P Hyland; H Mulcahy; K Sheahan; P R O' Connell; D P O' Donoghue; D C Winter
Journal:  Tech Coloproctol       Date:  2013-02-14       Impact factor: 3.781
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.